Tuyama AC et al. – Weight loss, dietary modification and treatment of underlying metabolic syndrome remain the mainstays of therapy once the diagnosis is established. There are no well–established pharmacological agents for treatment of Non–Alcoholic Steatohepatitis (NASH), although this is a subject of ongoing research. [more...]
© 2015 M3 USA Corporation. ALL Rights Reserved.